Core Entrustable Professional Activities in Clinical Pharmacology: Pearls for Clinical Practice Drug-Drug and Food-Drug Interactions

被引：10
|
作者：
Hermann, Robert [1 ,5 ]
Derendorf, Hartmut [2 ,5 ]
von Richter, Oliver [3 ,5 ]
Rostami-Hodjegan, Amin [4 ,5 ]
机构：
[1] Clin Res Appliance, D-63571 Gelnhausen, Germany
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[3] Sandoz Biopharmaceut, Clin Pharmacol, Holzkirchen, Germany
[4] Univ Manchester, Ctr Appl Pharmacokinet Res CAPKR, Manchester, Lancs, England
[5] DDI Workshop Org, Fac Int Marbach, Gelnhausen, Germany
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 58卷 / 06期
关键词：
SEROTONIN REUPTAKE; OATP TRANSPORTERS; ELDERLY-PATIENTS; P-GLYCOPROTEIN; HUMAN LIVER; METABOLISM; PHARMACOKINETICS; CONSEQUENCES; INHIBITION; MEDICATION;
D O I：
10.1002/jcph.1088
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：704 / 716
页数：13
相关论文
共 50 条
  • [41] Mechanisms and the clinical relevance of complex drug-drug interactions
    Roberts, Arthur G.
    Gibbs, Morgan E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 123 - 134
  • [42] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Vazquez, Marta
    Garcia-Carnelli, Carlos
    Maldonado, Cecilia
    Fagiolino, Pietro
    CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 : 27 - 42
  • [43] UDP-glucuronosyltransferases and clinical drug-drug interactions
    Kiang, TKL
    Ensom, MHH
    Chang, TKH
    PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) : 97 - 132
  • [44] Clinical Pharmacokinetics and Drug-Drug Interactions of Elbasvir/Grazoprevir
    Kiang, Tony K. L.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (05) : 509 - 531
  • [45] Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
    Ferri, Nicola
    Colombo, Elisa
    Corsini, Alberto
    HEMATOLOGY REPORTS, 2024, 16 (01) : 151 - 163
  • [46] Generating Evidence of Clinical Outcomes of Drug-Drug Interactions
    Bykov, Katsiaryna
    Gagne, Joshua J.
    DRUG SAFETY, 2017, 40 (02) : 101 - 103
  • [47] Clinical conundrums involving statin drug-drug interactions
    Lamprecht Jr, Donald G.
    Saseen, Joseph J.
    Shaw, Paul B.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2022, 75 : 83 - 89
  • [48] Drug-drug interactions in oncology - prevalence and clinical relevance
    Hinnerkort, A.
    Liekweg, A.
    Muellerleile, U.
    Tiede, S.
    Bruellke, N.
    Jaehde, U.
    ONKOLOGIE, 2010, 33 : 1 - 1
  • [49] Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics
    Donnenberg, Vera S.
    Mandic, Maja
    Rhee, John C.
    Burns, Timothy F.
    Meibohm, Bernd
    Korth-Bradley, Joan M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (08): : 947 - 955
  • [50] Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
    Florine A. Berger
    Heleen van der Sijs
    Matthijs L. Becker
    Teun van Gelder
    Patricia M. L. A. van den Bemt
    BMC Medical Informatics and Decision Making, 20
12345